Yang Lei, Zheng Rongshou, Wang Ning, Zhang Siwei, Chen Wanqing
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Email:
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Aug;48(8):663-8.
To analysis the incidence and mortality status of thyroid cancer in China, 2010.
Incidence and mortality data of thyroid cancer were derived from 145 cancer registries in China of 2010.Incidences, mortality, age-specific rates of thyroid cancer in different areas (urban and rural) were calculated. The incident cases and deaths were estimated using age-specific rates and national population data. Chinese census in 2000 and Segi's population were used for age-standardized incidence and mortality rates.
The registration areas covered a total of 158 403 248 population (92 433 739) in urban areas and 65 969 509 in rural areas, which accounted for 12.05% (158 403 248/1 314 873 293) of the total population of the whole country in 2010. The estimates of new cancer incident cases was 54 175 (male 12 962, female 41 213), with the crude incidence rate of 4.12/100 000 (54 175/1 314 873 293). Age-standardized incidence rates by Chinese standard population (ASIRC, 2000) and by world standard population (ASIRW) were 3.62/100 000 and 3.23/100 000, respectively, which accounted for 1.75% (54 175/3 093 039) of all malignant tumors in 2010. Male to female ratio was 1: 3.2, the incidence rate in urban areas was 1.46 times higher than that of rural areas. The estimates number of cancer deaths was 4 504 (male 1 529 cases and female 2 975 cases) in 2010 in China with the crude mortality rate of thyroid cancer 0.34/100 000 (4 504/1 314 873 293). Age-standardized mortality rates by Chinese standard population (ASIRC, 2000) and by world standard population (ASIRW) were 0.27/100 000 and 0.26/100 000, respectively, which accounted for 0.23% (4 504/1 956 662) of all malignant related deaths. The cumulative incidence and mortality rates (0-74 years old) were 0.32% and 0.03%, respectively. According to the data from 145 cancer registries, papillary carcinoma was the main pathology type, which accounted for 86.0% (6 237/7 253) of all malignant tumors.
The incidence and mortality rates of thyroid cancer in urban areas of China were higher than that in rural areas, and females had higher incidence rate of thyroid than males. The reasons related the higher incidence rate of thyroid cancer in urban China should be paid more attention to in the future.
分析2010年中国甲状腺癌的发病率和死亡率状况。
甲状腺癌的发病率和死亡率数据来源于2010年中国145个癌症登记处。计算不同地区（城市和农村）甲状腺癌的发病率、死亡率、年龄别发病率。利用年龄别发病率和全国人口数据估算发病例数和死亡例数。采用2000年中国人口普查数据和Segi人口数据对发病率和死亡率进行年龄标准化。
登记地区覆盖总人口158403248人（城市地区92433739人，农村地区65969509人），占2010年全国总人口的12.05%（158403248/1314873293）。估计癌症新发病例数为54175例（男性12962例，女性41213例），粗发病率为4.12/10万（54175/1314873293）。按中国标准人口（ASIRC，2000）和世界标准人口（ASIRW）计算的年龄标准化发病率分别为3.62/10万和3.23/10万，占2010年所有恶性肿瘤的1.75%（54175/3093039）。男女比例为1:3.2，城市地区发病率是农村地区的1.46倍。2010年中国估计癌症死亡例数为4504例（男性1529例，女性2975例），甲状腺癌粗死亡率为0.34/10万（4504/1314873293）。按中国标准人口（ASIRC，2000）和世界标准人口（ASIRW）计算的年龄标准化死亡率分别为0.27/10万和0.26/10万，占所有恶性肿瘤相关死亡的0.23%（4504/1956662）。累积发病率和死亡率（0至74岁）分别为0.32%和0.03%。根据145个癌症登记处的数据，乳头状癌是主要病理类型，占所有恶性肿瘤的86.0%（6237/7253）。
中国城市地区甲状腺癌的发病率和死亡率高于农村地区，女性甲状腺癌发病率高于男性。未来应更多关注中国城市地区甲状腺癌发病率较高的相关原因。
